Surgical treatment of prostate cancer in the XXI century: Da Vinci Si robotic system.

Prostate cancer is the most common cancer in men. In its early stages, when the cancer does not go beyond the prostate gland, as well as with a locally distributed process, the patient can be radically cured of this ailment. The most effective method of radical treatment of prostate cancer is its removal - radical prostatectomy, which allows in most cases to ensure a complete cure of the patient from this deadly disease. But the choice of treatment method in each specific case is decided by the patient himself when discussing his clinical situation in detail with a urologist and other specialists.

In cases where the patient is shown a radical prostatectomy, almost all surgical treatments for the removal of the prostate gland in the Urology department of the MCSC are carried out in the most modern and minimally invasive way at the moment - using the Da Vinci Si robotic surgical technique. 


This operation was calledRobot-assisted laparoscopic radical prostatectomy. In this case, the lymphoid tissue, in which the presence of cancer cells is possible, is also removed. Robotic technology has many advantages over open and even laparoscopic operations. Using the Da Vinci robot allows you to perform the operation minimally traumatic from small incisions on the abdominal wall of about 1.5 cm, thereby ensuring a reduction (or complete absence) of the pain symptom in the postoperative period. This also ensures the lowest risk of postoperative inflammation or infection of the wound.

Robotic technology allows you to isolate tissues and internal organs as precisely as possible, i.e. accurately and accurately, which in turn provides a more thorough oncological result (ablasticity). The operation is almost bloodless, so that in almost 100% of cases there is no need for blood transfusion to the patient.

a clear 3D picture of the operating field, the maximum possible magnification, the small size of the unique working tools ("robot hands"), the absence of even a minimal tremor – all this is very important when performing radical prostatectomy, because the prostate is located in a narrow anatomical space – in the small pelvis. 

This is especially true for men, because the use of Da Vinci robotic technology can provide the patient with the ability to retain urine, and in the absence of oncological contraindications-to preserve the neurovascular bundles, leaving a good chance of restoring erectile function. 

All these advantages ultimately lead to the shortest possible rehabilitation period, which allows you to reduce the patient's stay in the hospital, quickly recover and return the patient to normal daily activities and even to work. Most patients can return to normal activity within two weeks. For comparison, this period after the" open " operation stretches to eight weeks.

The department's robotic team Urology MCSC consists of experienced and trained urologist surgeons, nurses, and technicians who perform dozens of robotic surgeries every month. All specialists have completed foreign internships in leading European clinics in Belgium, Switzerland and France for training in robotic technology.  
At the XV Congress of the Russian Society of Urology "Urology in the XXI century" held in St. Petersburg in September 2015, for the first time in the history of Russian urology, a separate section "Robot-assisted Urology" was held under the chairmanship of the chief urologist of the Russian Federation and Moscow, Prof. Pushkarya D. Yu. and with the active participation of leading specialists in the field of robotic urology EAU (European Society Urologists). This event once again marked the advantage of this type of surgery and its inevitable predominance in the near future over outdated technologies. TheDepartment of Urology of the MCSC in the framework of the robot section was proud to present its achievements in the field of robotic urology. 

In the urology department of the MCSC, all possible types of modern examination and effective treatment of prostate cancer are available to patients. 



GBUZ Moscow Clinical Scientific Center named after Loginov MHD